For global biotech company Novozymes, failing to incorporate the Sustainable Development Goals into the way they work is not an option.
The company is embedding an SDG assessment framework in its innovation pipeline and using it to help determine what products or models it will take to market, said Claus Stig Pedersen, Novozyme’s head of corporate sustainability affairs.
As a Devex Impact associate editor, Adva leads coverage of the intersection of business and international development. From partnerships to trade and social entrepreneurship to impact investing, she enjoys exploring the role the private sector and private capital play in development. Previously, she has worked as a reporter at newspapers in both the U.S. and South Africa. Most recently, she has been ghostwriting a memoir for a former child slave and NGO founder in Ghana.
Subscribe to Devex Newswire
Top international development headlines emailed to you every day